Lowering of serum cholesteryl ester transfer protein - But not lecithin:cholesterol acyltransferase-activity levels by hypocholesterolemic drugs in the rabbit

Cardiovascular Drugs and Therapy

Volumn 12, Issue 1, 1998, Pages 13-18

  Meijer, G W ^a,c   Groener, J E M ^b,d   Beynen, A C ^a   Van Tol, A ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

CETP; Cholesterol; Cholestyramine; LCAT; Lipoproteins; Rabbit; Simvastatin

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; COLESTYRAMINE; HYPOCHOLESTEROLEMIC AGENT; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; SIMVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; ENZYME ACTIVITY; LIPOPROTEIN METABOLISM; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CARRIER PROTEINS; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTYRAMINE; GLYCOPROTEINS; LIPOPROTEINS; MALE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; RABBITS; SIMVASTATIN;

EID: 0031919638     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007773011736     Document Type: Article

References (34)

1. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-37.
2. Shih DM, Gu L, Hama S, et al. Genetic-dietary regulation of serum praoxonase expression and its role in atherogenesis in a mouse model. J Clin Invest 1996;97:1630-1639.
3. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-228.
4. Tall AR. Plasma cholesteryl ester transfer protein (review). J Lipid Res 1993;34:1255-1274.
5. Steinberg D. A docking receptor for HDL cholesterol esters. Science 1996;271:460-461.
6. Hayek T, Masucci-Magoulas L, Jiang X, et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest 1995;96:2071-2074.
7. Ha YC, Barter PJ. Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. Comp Biochem Physiol 1982;71B:265-269.
8. Zilversmit DB. Lipid transfer proteins. J Lipid Res 1984;25: 1563-1569.
9. Son YSC, Zilversmit DB. Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis 1986;6: 345-351.
10. Groener, JEM, Van Ramshorst EM, Katan MB, Mensink RP, Van Tol A. Diet-induced alteration in the activity of plasma lipid transfer protein in normolipidemic human subjects. Atherosclerosis 1991;87:221-226.
11. Hoffman WF, Alberts AW, Anderson PS, Chen JS, Smith RL, Willard AK. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivates of mevinolin. J Med Chem 1986;29:849-852.
12. Cighetti G, Bosisio E, Galli G, Galli-Kienle M. The effect of cholestyramine on liver HMG-CoA reductase and cholesterol 7α-hydroxylase in various laboratory animals. Life Sci 1983;33:2483-2488.
13. Andersen JM, Turley SD, Dietschy JM. Relative rates of sterol synthesis in the liver and various extrahepatic tissues of normal and cholesterol-fed rabbits. Relationship to plasma lipoprotein and tissue cholesterol levels. Biochim Biophys Acta 1982;711:421-430.
14. Van Lith HA, Meijer GW, Haller M, Beynen AC. Serum pseudocholinesterase activity in rabbits fed simvastatin. Biochem Pharmacol 1991;41:460-461.
15. Meijer GW, Van der Palen JGP, De Vries H, et al. Evaluation of the use of serum lathosterol concentration to assess whole-body cholesterol synthesis in rabbits. J Lipid Res 1992;33:281-286.
16. Beynen AC, West CE, Katan MB, Van Zutphen LFM. Hyperresponsiveness of plasma cholesterol to dietary cholesterol, saturated fatty acids and casein in inbred rabbits. Nutr Rep Int 1986;33:65-70.
17. Terpstra AHM, Woodward CJH, Sanchez-Muniz FJ. Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: Visualization by pre-staining and rapid separation of serum lipoproteins from small volumes of serum. Anal Biochem 1981;111:149-157.
18. Sullivan DR, Kruijswijk Z, West CE, Kohlmeier M, Katan MB. Determination of serum triglycerides by an accurate enzymatic method not affected by free glycerol. Clin Chem 1985;31:1227-1228.
19. Speijer H, Groener JEM, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991;90:159-168.
20. Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986;32:283-286.
21. Glomset JA, Wright JL. Some properties of a cholesterol esterifying enzyme in human plasma. Biochim Biophys Acta 1964;89:266-276.
22. Meijer GW, Demacker PNM, Van Tol A, et al. Plasma activities of lecithin-cholesterol acyltransferase, lipid transfer proteins and post-heparin lipases in inbred strains of rabbits hypo-responsive or hyper-responsive to dietary cholesterol. Biochem J 1993;293:729-734.
23. Quig DW, Zilversmit DB. Dissociation between cholesterol secretion and plasma lipid transfer activity in rabbits. FASEB J 1988;2:2712-2716.
24. Ahnadi CE, Berthe;zène F, Ponsin G. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects. Atherosclerosis 1993;99:219-228.
25. Hibino T, Sakuma N, Sato T, Yoneyama A, Fujinami T. Decrease in plasma cholesteryl-ester transfer protein activity with simvastatin treatment in patients with type IIa hypercholesterolemia. Curr Ther Res 1996;57:42-47.
26. Zhao SP, Smelt AHM, Van den Maagdenberg AMJM, et al. Plasma lipoproteins in familial dysbetalipoproteinemia associated with apolipoproteins E2(Arg158→Cys), E3-Leiden, and E2(Lys146→Gln), and effects of treatment with simvastatin. Arterioscler Thromb 1994;14:1705-1716.
27. Albers JJ, Chen CH, Adolphson JL. Lecithin:cholesterol acyltransferase (LAGT) mass: Its relationship to LCAT activity and cholesterol esterification rate. J Lipid Res 1981;22:1206-1213.
28. Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans -Review. J Lipid Res 1993;34:1637-1659.
29. Kovanen PT, Brown MS, Basu SK, Bilheimer DW, Goldstein JL. Saturation and suppression of hepatic lipoprotein receptors: A mechanism for the hypercholesterolemia of cholesterol-fed rabbits. Proc Natl Acad Sci USA 1981;78:1396-1400.
30. Kovanen PT, Bilheimer DW, Goldstein JL, Jaramillo JJ, Brown MS. Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci USA 1981;78:1194-1198.
31. O'Meara NMG, Devery RAM, Owens D, Collins PB, Johnson AH, Tomkin GH. Serum lipoproteins and cholesterol metabolism in 2 hypercholesterolaemic rabbit models. Diabetologica 1991;34:139-143.
32. Groener JEM, Van Gent T, Van Tol A. Effect of lipid transfer protein on plasma lipid, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat. Biochim Biophys Acta 1989;1002:93-100.
33. Jiang XC, Masucci-Magoulis L, Mar J, et al. Down-regulation of messenger RNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein-Mechanism to explain accumulation of lipoprotein-B particles. J Biol Chem 1993; 268:27406-27412.
34. Masucci-Magoulas L, Plump A, Jiang XC, Walsh A, Breslow JL, Tall AR. Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice-A novel mechanism signals changes in plasma cholesterol levels. J Clin Invest 1996;97:154-161.